Main Content

Scientific & Medical Advisory Board (SMAB)

The SMAB is composed of scientists nominated from each member organisations’ scientific & medical advisory boards.

Its purpose is to

  • help national research efforts to produce the best possible results through the exchange of information and co-operation
  • inform and advise Retina International and national Retina International member societies in medical and research matters

SMAB Members

Chairmen:

  • Prof. Eberhart Zrenner
    University Eye Hospital, Tübingen
  • Prof. Joe G. Hollyfield
    The Cleveland Clinic Foundation, Cleveland, USA

Secretary:

  • Prof. Gerald J. Chader
    Doheny Eye Institute, Los Angeles, CA, USA

Members:

  • Australia
    Prof. Erica Fletcher
    University of Melbourne, Parkville Victoria 
    Dr. Michael Kalloniatis
    University of New South Wales, Sydney
  • Brazil
    Dr. Juliana Maria Sallum
    Sao Paulo
    Dr. Rosane Resende
    Rio de Janeiro
  • Canada
    Dr. Elise Heon
    The Hospital for Sick Children, Toronto
    Dr. Robert S. Molday
    University of British Columbia, Vancouver
  • China
    Prof. Xia Xiaoping
    Zhongshan University, Guangzhou
  • Denmark
    Dr. Thomas Rosenberg
    National Eye Clinic for Visually Impaired, Hellerup
  • Finland
    Dr. Eeva-Marja Sankila
    Helsinki University Eye Hospital, Helsinki
    Dr. Sirkka-Liisa Rudanko
    Finnish Federation of the Visually Impaired, Ilris
  • France
    Dr. Josseline Kaplan
    Hôpital Necker-Enfants Malades, Paris
    Prof. Jean-Louis Dufier
    Hôpital Necker - Enfants Malades, Paris
  • Germany
    Prof. Andreas Gal
    Institut für Humangenetik, Hamburg
    Prof. Eberhart Zrenner
    Universitätsaugenklinik Tübingen
  • Greece
    Prof. Michael Moschos
    University of Athens, Athens
    Dr. Mirto Papaioannou
  • Hong Kong
    MD Stephen T.S. Lam
    Clinical Genetics Service, Dept. of Health, Kowloon
    Prof. Shea-ping Yip
    The Hong Kong Polytechnic University, Kowloon
  • India
    Dr. S. Natarajan
    Aditya Jyot Eye Hospital, Aashirwad, Mumbai
  • Ireland
    Prof. Peter Humphries
    Trinity College, Wellcome Ocular Genetics Unit, Dublin
  • Italy
    Prof. Nicola Orzalesi
    Ospedale S. Paolo, Clinica Oculistica, Milano
    Prof. Alfredo Ciccodicola
    IGB Institute of Genetics and Biophisics, Napoli
  • Japan
    MD,PhD Shuichi Yamamoto
    Prof. Toshio Maruo
    Teikyo University School of Medicine, Tokyo
  • Lithuania
    Ph. D. Julia Vidute Archiuliene
    Laboratory of Visual Rehabilitation, Kaunas Medical Academy
    Prof. Vaidutis Kucinskas
    Vilnius University Hospital, Vilnius
  • Netherlands
    Dr. Frans P.M. Cremers
    Universiteit van Nijmegen, Nijmegen
    Dr. Arthur A.B. Bergen
    The Netherlands Ophthalmic Research Institute, Amsterdam
  • New Zealand
    Dr. Dianne Sharp
    Auckland
    Dr. Andrea Vincent
    Auckland
  • Norway
    MD, PhD. Ruth Riise
    Central Hospital in Hedmark, Hamar
    Ragnheidur Bragadóttir
    Ulleval University Hospital, Oslo
  • Pakistan
    Dr. Bashir Ahmed Chohan
    Chohan Eye Hospital, Islamabad
    Prof. Aslam K. Malik
    Islamabad
  • South Africa
    Dr. Linda Visser
    Natal Medical School, University of Natal, Congella
    Prof. Raj Ramesar
    UCT Medical School, Cape Town
  • Spain
    Dr .Concepción Vilela
    Hospital La Fe, Servicio de Neurofisiologia, Valencia
    Dr. Carmen Ayuso García
    Fundación Jiménez Diaz, Genetics Dept., Madrid
  • Sweden
    Prof. Sten Andréasson
    University Hospital of Lund, Lund
    Prof. Fredrik Ghosh
    University of Lund, Lund
  • Switzerland
    Prof. Günter Niemeyer
    Zürich
    Prof. Albert Schinzel
    Institut für medizinische Genetik, Zürich
  • United Kingdom
    Prof. Anthony Moore
  • UCL Institute of Ophthalmology, London 
    Prof. John Marshall
    UCL Institute of Ophthalmology, London
  • USA
    MD. Alan M. Laties
    University of Pennsylvania Medical School, Philadelphia
    Dr. Stephen M. Rose
    The Foundation Fighting Blindness, Owings Mills

 


End of article

 

Search

Search

Search

Adapt your Font Size

Font-Size:

Retina International Statement

Retina International Is Seeking A Cure For
Retinitis Pigmentosa (RP), Macular Degeneration, Usher Syndrome and Allied Retinal Dystrophies